Literature DB >> 26358617

Quantitative structure-activity relationship: promising advances in drug discovery platforms.

Tao Wang1, Mian-Bin Wu1, Jian-Ping Lin, Li-Rong Yang1.   

Abstract

INTRODUCTION: Quantitative structure-activity relationship (QSAR) modeling is one of the most popular computer-aided tools employed in medicinal chemistry for drug discovery and lead optimization. It is especially powerful in the absence of 3D structures of specific drug targets. QSAR methods have been shown to draw public attention since they were first introduced. AREAS COVERED: In this review, the authors provide a brief discussion of the basic principles of QSAR, model development and model validation. They also highlight the current applications of QSAR in different fields, particularly in virtual screening, rational drug design and multi-target QSAR. Finally, in view of recent controversies, the authors detail the challenges faced by QSAR modeling and the relevant solutions. The aim of this review is to show how QSAR modeling can be applied in novel drug discovery, design and lead optimization. EXPERT OPINION: QSAR should intentionally be used as a powerful tool for fragment-based drug design platforms in the field of drug discovery and design. Although there have been an increasing number of experimentally determined protein structures in recent years, a great number of protein structures cannot be easily obtained (i.e., membrane transport proteins and G-protein coupled receptors). Fragment-based drug discovery, such as QSAR, could be applied further and have a significant role in dealing with these problems. Moreover, along with the development of computer software and hardware, it is believed that QSAR will be increasingly important.

Keywords:  comparative molecular field analysis; comparative molecular similarity indices analysis; machine learning; quantitative structure–activity relationship; rational design; virtual screening

Mesh:

Year:  2015        PMID: 26358617     DOI: 10.1517/17460441.2015.1083006

Source DB:  PubMed          Journal:  Expert Opin Drug Discov        ISSN: 1746-0441            Impact factor:   6.098


  17 in total

1.  3D-QSAR AND CONTOUR MAP ANALYSIS OF TARIQUIDAR ANALOGUES AS MULTIDRUG RESISTANCE PROTEIN-1 (MRP1) INHIBITORS.

Authors:  Prathusha Kakarla; Madhuri Inupakutika; Amith R Devireddy; Shravan Kumar Gunda; Thomas Mark Willmon; K C Ranjana; Ugina Shrestha; Indrika Ranaweera; Alberto J Hernandez; Sharla Barr; Manuel F Varela
Journal:  Int J Pharm Sci Res       Date:  2016-02-01

Review 2.  Computational functional group mapping for drug discovery.

Authors:  Olgun Guvench
Journal:  Drug Discov Today       Date:  2016-07-05       Impact factor: 7.851

Review 3.  Large-Scale Prediction of Drug-Target Interaction: a Data-Centric Review.

Authors:  Tiejun Cheng; Ming Hao; Takako Takeda; Stephen H Bryant; Yanli Wang
Journal:  AAPS J       Date:  2017-06-02       Impact factor: 4.009

4.  Harnessing Human Microphysiology Systems as Key Experimental Models for Quantitative Systems Pharmacology.

Authors:  D Lansing Taylor; Albert Gough; Mark E Schurdak; Lawrence Vernetti; Chakra S Chennubhotla; Daniel Lefever; Fen Pei; James R Faeder; Timothy R Lezon; Andrew M Stern; Ivet Bahar
Journal:  Handb Exp Pharmacol       Date:  2019

Review 5.  Artificial intelligence and machine-learning approaches in structure and ligand-based discovery of drugs affecting central nervous system.

Authors:  Vertika Gautam; Anand Gaurav; Neeraj Masand; Vannajan Sanghiran Lee; Vaishali M Patil
Journal:  Mol Divers       Date:  2022-07-11       Impact factor: 3.364

6.  Structure-based design and synthesis of a novel long-chain 4''-alkyl ether derivative of EGCG as potent EGFR inhibitor: in vitro and in silico studies.

Authors:  Satyam Singh; Revathy Sahadevan; Rajarshi Roy; Mainak Biswas; Priya Ghosh; Parimal Kar; Avinash Sonawane; Sushabhan Sadhukhan
Journal:  RSC Adv       Date:  2022-06-16       Impact factor: 4.036

7.  Characterizing the Hot Spots Involved in RON-MSPβ Complex Formation Using In Silico Alanine Scanning Mutagenesis and Molecular Dynamics Simulation.

Authors:  Omid Zarei; Maryam Hamzeh-Mivehroud; Silvia Benvenuti; Fulya Ustun-Alkan; Siavoush Dastmalchi
Journal:  Adv Pharm Bull       Date:  2017-04-13

8.  Hybridizing Feature Selection and Feature Learning Approaches in QSAR Modeling for Drug Discovery.

Authors:  Ignacio Ponzoni; Víctor Sebastián-Pérez; Carlos Requena-Triguero; Carlos Roca; María J Martínez; Fiorella Cravero; Mónica F Díaz; Juan A Páez; Ramón Gómez Arrayás; Javier Adrio; Nuria E Campillo
Journal:  Sci Rep       Date:  2017-05-25       Impact factor: 4.379

Review 9.  Transfer and Multi-task Learning in QSAR Modeling: Advances and Challenges.

Authors:  Rodolfo S Simões; Vinicius G Maltarollo; Patricia R Oliveira; Kathia M Honorio
Journal:  Front Pharmacol       Date:  2018-02-06       Impact factor: 5.810

10.  Quantum chemical predictions of water-octanol partition coefficients applied to the SAMPL6 logP blind challenge.

Authors:  Michael R Jones; Bernard R Brooks
Journal:  J Comput Aided Mol Des       Date:  2020-01-30       Impact factor: 3.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.